Pharma Marketing Network

DECEMBER 4, 2024

As we approach 2025, emerging trends are reshaping how the industry engages with patients and healthcare providers. Adhering to guidelines from the FDA and other governing bodies ensures that campaigns remain effective without crossing ethical boundaries. Navigating these requires a fine balance between creativity and compliance.

Marketing 52

Marketing Pharma Media Education 52

Pharma Marketing Network

NOVEMBER 1, 2024

The world of pharma marketing is changing rapidly, and 2025 will be no exception. So, what will be the top challenges in 2025, and how can pharma marketers tackle them? Data Privacy and Compliance Challenges Data privacy is one of the most pressing concerns in 2025, especially with new regulations being enacted globally.

Marketing 52

Marketing Pharma Ethics Healthcare Provider 52

Pharma Marketing Network

DECEMBER 17, 2021

Its sustainability platform, fueled by its Health for Humanity 2025 Goals, contributes to the global effort to achieve a majority of the SDGs by supporting 11 of the 17, spanning the spheres of global health, social justice, environmental stewardship, and responsible business practices. Ethics is a skill.” Why make it inviting?

Pharma 103

Pharma Ethics Recruitment Government 103

Pharma Marketing Network

OCTOBER 17, 2024

As we approach 2025, the pharmaceutical industry is witnessing a seismic shift in marketing strategies, driven by technological advancements and evolving consumer expectations. However, the rise of influencer partnerships also necessitates careful consideration of ethical and regulatory guidelines.

Marketing 52

Marketing Healthcare Healthcare Pharma 52

European Pharmaceutical Review

FEBRUARY 28, 2024

Starting in 2025, health technology assessment (HTA) experts from across Europe will join forces to produce joint clinical assessment (JCA) reports, which will be used to support national health economic assessments as well as inform pricing and reimbursement discussions. A more flexible approach is needed. Internet] European Commission.

Patients 97

Patients Ethics Healthcare Healthcare 97

Pharmaceutical Technology

FEBRUARY 23, 2023

Most importantly, it gives more power to already influential tech giants and puts focus on the commercialization of biohacks rather than their health consequences or ethics. billion by 2025. Thus, we can see the technocratic rule of this age and the pervasiveness of tech hustle culture as driving biohacking.

Media 111

Media Healthcare Healthcare Ethics 111